13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0000904454-24-000458
Total Value
$352.3M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIBERTY BROADBAND CORP | LBRDP | 1,994,510 | $109.3M | 31.04% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 729,464 | $28.3M | 8.04% |
| 3 | ASCENDIS PHARMA A/S | ASND | 189,272 | $25.8M | 7.33% |
| 4 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 638,352 | $24.0M | 6.83% |
| 5 | ARGENX SE | ARGX | 54,028 | $23.2M | 6.60% |
| 6 | SAREPTA THERAPEUTICS INC | SRPT | 132,835 | $21.0M | 5.96% |
| 7 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 388,835 | $17.1M | 4.85% |
| 8 | ARVINAS INC | ARVN | 574,378 | $15.3M | 4.34% |
| 9 | ACADIA PHARMACEUTICALS INC | ACAD | 905,384 | $14.7M | 4.18% |
| 10 | TRAVERE THERAPEUTICS INC | TVTX | 1,776,728 | $14.6M | 4.15% |
| 11 | CYTOKINETICS INC | CYTK | 256,449 | $13.9M | 3.94% |
| 12 | GALAPAGOS NV | GLPGF | 542,762 | $13.4M | 3.82% |
| 13 | RELAY THERAPEUTICS INC | RLAY | 1,605,346 | $10.5M | 2.97% |
| 14 | PROTHENA CORP PLC | PRTA | 433,471 | $8.9M | 2.54% |
| 15 | EYEPOINT PHARMACEUTICALS INC | EYPT | 707,404 | $6.2M | 1.75% |
| 16 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $5.5M | 1.55% |
| 17 | CHURCHILL CAPITAL CORP VII | 17144M110 | 548,000 | $191,800 | 0.05% |
| 18 | MONEYHERO LIMITED | MNYWW | 895,000 | $71,600 | 0.02% |
| 19 | CONCORD ACQUISITION CORP II | CNDAW | 408,333 | $44,917 | 0.01% |
| 20 | SWIFTMERGE ACQUISITION CORP | G63836111 | 490,000 | $39,200 | 0.01% |
| 21 | LAKESHORE BIOPHARMA CO LTD | G9845F117 | 489,999 | $33,369 | 0.01% |
| 22 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 655,200 | $27,584 | 0.01% |
| 23 | COMPASS DIGITAL ACQUISITION CORP | COMP | 459,906 | $27,548 | 0.01% |
| 24 | MARBLEGATE ACQUISITION CORP | 56608A113 | 735,000 | $26,828 | 0.01% |
| 25 | CALIDI BIOTHERAPEUTICS INC | CLDWW | 125,000 | $25,000 | 0.01% |